BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.
BIOCRYST PHARMACEUTICALS INC's stock currently trades at $6.79 with a market capitalization of $1.6B. The Healthcare company's stock moved following the disclosure.